Skip to Content

Medications for Hepatic Encephalopathy

Drugs associated with Hepatic Encephalopathy

The following drugs and medications are in some way related to, or used in the treatment of this condition.

What is Hepatic Encephalopathy: A group of symptoms that may occur when there is damage to the brain and nervous system as a complication of liver disorders, characterized by various neurologic symptoms including changes in reflexes, changes in consciousness, and behavior changes that can range from mild to severe.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
lactulose Rx B N 3 reviews
8.0

Generic name: lactulose systemic

Brand names:  Enulose, Generlac, Kristalose, Constulose

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Xifaxan Rx C N 2 reviews
9.0

Generic name: rifaximin systemic

Drug class: miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
rifaximin Rx C N 3 reviews
8.0

Generic name: rifaximin systemic

Brand name:  Xifaxan

Drug class: miscellaneous antibiotics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Enulose Rx B N 1 review
9.0

Generic name: lactulose systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Generlac Rx B N 1 review
10

Generic name: lactulose systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Kristalose Rx B N Add review Add

Generic name: lactulose systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Constulose Rx B N Add review Add

Generic name: lactulose systemic

Drug class: laxatives

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
neomycin Rx D N Add review Add

Generic name: neomycin systemic

Brand names:  Neo-Fradin, Neo-Tab

Drug class: aminoglycosides

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Neo-Fradin Rx D N Add review Add

Generic name: neomycin systemic

Drug class: aminoglycosides

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Neo-Tab Rx D N Add review Add

Generic name: neomycin systemic

Drug class: aminoglycosides

For consumers: dosage, interactions, side effects

 
Showing all

Learn more about Hepatic Encephalopathy

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N The drug is not subject to the Controlled Substances Act.
1 The drug has a high potential for abuse. The drug has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug under medical supervision.
2 The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
3 The drug has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
4 The drug has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
5 The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide